Recent progress

Clinical trials
AkkoLens has successfully completed clinical trials and obtained full Proof of Concept.

Accommodation and safety have been confirmed, allowing patients to see Far and Near without Glasses
• Accommodation over a significant range
• Virtually all patients are “spectacle-free” at up to 2½ years post-op
• No significant side effects
• Clinical trials will be expanded to more clinics in more countries

Registration and Sales
• CE Mark is anticipated
• Manufacturing process in place

Investment opportunities
The Company is an attractive additional investment at this stage. Potential investors are invited to contact Dr Michiel Rombach at This email address is being protected from spambots. You need JavaScript enabled to view it.

content rechts